ImageneBio (IMA) Income from Continuing Operations (2020 - 2025)

ImageneBio has disclosed Income from Continuing Operations across 6 years of filings, most recently posting 24779000.0 for Q3 2025.

• Income from Continuing Operations for Q3 2025 came in at 24779000.0, down 678.48% year-over-year; the trailing twelve-month figure through Sep 2025 was 51129000.0 (up 3.0% YoY), and the FY2024 annual result was 49234000.0, up 27.77% from the prior year.
• Income from Continuing Operations came in at 24779000.0 for Q3 2025 at ImageneBio, down from 2767000.0 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 2797000.0 in Q4 2021 to a low of 24779000.0 in Q3 2025.
• The 5-year median for Income from Continuing Operations is 14515000.0 (2021), against an average of 13444578.95.
• Across the five-year window, Income from Continuing Operations surged 110.74% in 2021 and slumped 678.48% in 2025, its largest moves.
• ImageneBio's Income from Continuing Operations stood at 2797000.0 in 2021, then slumped by 604.0% to 14097000.0 in 2022, then sank by 39.4% to 19651000.0 in 2023, then climbed by 11.06% to 17478000.0 in 2024, then plunged by 41.77% to 24779000.0 in 2025.
• The last three Income from Continuing Operations figures came in at 24779000.0 (Q3 2025), 2767000.0 (Q2 2025), and 6105000.0 (Q1 2025), per Business Quant data.